Dr. Palaskas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 2014 - 2017
- Baylor College of MedicineResidency, Internal Medicine, 2011 - 2014
- The University of Texas Health Science Center at San AntonioClass of 2011
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2027
- TN State Medical License 2023 - 2026
- TX State Medical License 2014 - 2026
- WA State Medical License 2023 - 2026
- AL State Medical License 2024 - 2025
- GA State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Publications & Presentations
PubMed
- Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal.Omair Ahmed, Nicholas E King, Muhammad Ahmad Qureshi, Abira Afzal Choudhry, Muhammad Osama
European Heart Journal. 2024-11-20 - Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospe...Felipe Soto-Lanza, Lydia Glick, Colin Chan, Linda Zhong, Nathaniel Wilson
Clinical Lung Cancer. 2024-11-01 - Diaphragmatic Myopathy Associated with Dual Immune Checkpoint Inhibitors in a Patient with Renal Cell Carcinoma.Jeremy R Walder, Saadia A Faiz, Sudhakar Tummala, Shiao-Pei Weathers, Nicolas L Palaskas
Journal of Immunotherapy and Precision Oncology. 2024-11-01
Press Mentions
- MD Anderson Research Highlights: SITC 2024 Special EditionNovember 9th, 2024
- Immune Checkpoint Inhibitors Linked to Range of Adverse Heart EffectsJuly 12th, 2022
- Allogene Therapeutics to Present at the Virtual 39th Annual J.P. Morgan Healthcare ConferenceNovember 12th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: